Search results
Results from the WOW.Com Content Network
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, sometimes called foxy methoxy or simply foxy [2]) is a psychedelic tryptamine and the methoxy derivative of diisopropyltryptamine (DiPT). Pharmacology [ edit ]
5-MeO-MiPT is a psychedelic and hallucinogen of the tryptamine family. It used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT. It is commonly used as a "substitute" for 5-MeO-DiPT because of the very similar structure and effects.
5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), also known as O-methylbufotenin or mebufotenin (INN Tooltip International Nonproprietary Name), is a naturally occurring psychedelic of the tryptamine family. [5] [1] [4] [2] It is found in a wide variety of plant species, and is also secreted by the glands of at least one toad species, the Colorado ...
5-MeO EiPT is a psychedelic of the tryptamine class that has been sold online as a designer drug. [1] [2] ... 5-MeO-DiPT; 5-MeO-DMT; 5-MeO-DPT; 5-MeO-MiPT; EiPT ...
5-Methoxy-N-propyl-N-isopropyltryptamine (5-MeO-PiPT) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It acts as a 5-HT 1A and 5-HT 2A receptor agonist, [ 1 ] with an EC 50 of 13.8 nM and an efficacy of 89% (vs 5-HT), [ 2 ] and has been sold as a designer drug , first being identified in 2021 in British ...
5-Methoxytryptamine (5-MT, 5-MeO-T, or 5-OMe-T), also known as serotonin methyl ether or O-methylserotonin and as mexamine, is a tryptamine derivative closely related to the neurotransmitters serotonin and melatonin. [3] It has been shown to occur naturally in the body in low levels, especially in the pineal gland.
5-MeO-EPT is a psychedelic tryptamine derivative which has been sold as a designer drug. [1] [2] Legality. 5-MeO-EPT is illegal in Singapore [3] and Japan, [4] as ...
An assortment of several designer drugs. Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.